Clinical Trials Logo

Filter by:
NCT ID: NCT02649725 Recruiting - Clinical trials for Patient's Satisfaction

Patients Satisfaction With the Outcomes of Expensive Cytotoxic Agents

Start date: January 2016
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to determine whether there is positive (beneficial) impact of expensive cytotoxic agents on the cancer patients. It is a questionnaire based study that will be filled by the cancer patients without obligations.

NCT ID: NCT02646202 Recruiting - Clinical trials for Gastroesophageal Varices

Scleroligation for Eradication of Gastroesophageal Varices.

Start date: January 2015
Phase: Phase 3
Study type: Interventional

Gastric varices occur in 5-33% of patients with portal hypertension. Concomitant gastro esophageal varices are the most common type. Both endoscopic sclerotherapy and band ligation are very effective in controlling acute esophageal varices bleeding and preventing rebleeding.

NCT ID: NCT02646137 Recruiting - Liver Cancer Clinical Trials

Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

Start date: January 2015
Phase: Phase 3
Study type: Interventional

Hepatocellular carcinoma is the third most common cause of cancer-related mortality. In recent years, transarterial chemoembolization, radio frequency ablation and microwave ablation have been accepted as treatment modalities for patients with surgically unresectable hepatocellular carcinoma.

NCT ID: NCT02644733 Recruiting - Clinical trials for Intraabdominal Hypertension

Effect of Different Body Position on Intraabdominal Pressure in Mechanically Ventilated Patients

Ghada
Start date: December 2016
Phase: N/A
Study type: Observational

Measuring intraabdominal pressure in the semi-recumbent position and supine position.

NCT ID: NCT02644304 Recruiting - Clinical trials for Female Reproductive Problem

Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome

Start date: May 2015
Phase: Phase 2
Study type: Interventional

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive aged women and affects approximately 5-12 % of the female population. In 2003 in Rotterdam , Rotterdam diagnostic criteria were redefined PCOS as affected individuals must have two out of the following three criteria: 1. Oligo- and/or anovulation, (ovulation occurs less than once every 35 days). 2. Hyperandrogenism, clinical signs include hirsutism, acne, alopecia, and frank virilization, while chemical indicators include raised concentrations of total testosterone and androstenedione , and elevated free androgen index. 3. Polycystic ovaries on sonographic examination, presence of 12 or more follicles in either ovary measuring 2-9 mm in diameter, increased ovarian volume more than 10 cm3 and/or increase in stromal echogenicity. Clearly, according to the Rotterdam diagnostic criteria, the majority of women with PCOS can be diagnosed without the need of laboratory examinations. Clomiphene citrate (CC) is still the first-line medication for the induction of ovulation. It is an anti-estrogenic compound made up of two isomers, enclomiphene and zuclomiphene; the latter being the more potent of the two. It is a non-steroidal compound closely resembling estrogen. CC acts by blocking estrogen receptors, particularly in the hypothalamus, thereby signaling a lack of circulating estrogens and inducing a change in the pulsatile release of gonadotrophin-releasing hormone (GnRH). This induces release of follicle stimulating hormone from the anterior pituitary and is often enough to set the cycle of events leading to ovulation into motion. Cabergoline, ergot-derived dopamine agonists with a very long half life, is an effective prolactin suppressor. Cabergoline oral administration contains a weekly dose of 0.5 - 3 mg, which could be increased, if needed, to twice a week. This medicine has slight dopamine agonistic side effects, headache being the most common one. Treatment in the very beginning should start with a partial dose (half a pill) at bedtime with a small amount of food. Low incidence of side effects and its weekly dose has made Cabergoline a choice drug for treatment of related diseases.

NCT ID: NCT02643186 Recruiting - Clinical trials for Vaginal Misoprostol and Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy

Vaginal Misoprostol Versus Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy

Start date: July 2015
Phase: Phase 4
Study type: Interventional

The study aims at comparison between the effect of preoperative misoprostol and bilateral uterine artery ligation regarding their effect to decrease blood loss in transabdominal myomectomy.

NCT ID: NCT02642874 Recruiting - Liver Cirrhosis Clinical Trials

Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients

Start date: April 1, 2017
Phase: Phase 3
Study type: Interventional

Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.

NCT ID: NCT02642601 Recruiting - Clinical trials for Difficult Embryo Transfer

Role of Indomethacin in Difficult Embryo Transfer.

Start date: March 2014
Phase: Phase 2/Phase 3
Study type: Interventional

the aim of the study is to assess the role of indomethacin in cases of difficult embryo transfer in intracytoplasmic sperm injection cycles.

NCT ID: NCT02635425 Recruiting - Infertility Clinical Trials

Aspiration of Limited Number of Follicles to Prevent Severe Ovarian Hyperstimulation Syndrome

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of single ovarian puncture to retrieve 7eggs only in prevention of severe ovarian hyperstimulation syndrome.

NCT ID: NCT02633995 Recruiting - Preeclampsia Clinical Trials

Spinal Anaesthesia and Severe Preeclampsia

Start date: December 2015
Phase: N/A
Study type: Observational

The use of spinal anesthesia in pre-eclamptic pregnant woman is of considerable benefit, as these patients present particular hazards with general anaesthesia, such as concerns for rapid airway control and cerebral blood flow alterations during induction of general anaesthesia and intubation However, the incidence of hypotension is high during spinal anesthesia for Cesarean section and it may approach values up to 95 %.